Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
53.31
-1.16 (-2.13%)
At close: Jun 26, 2026
Shanghai Rendu Biotechnology Employees
Shanghai Rendu Biotechnology had 239 employees as of December 31, 2025. The number of employees decreased by 96 or -28.66% compared to the previous year.
Employees
239
Change (1Y)
-96
Growth (1Y)
-28.66%
Revenue / Employee
683.42K CNY
Profits / Employee
58.00K CNY
Market Cap
2.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 239 | -96 | -28.66% |
| Dec 31, 2024 | 335 | -23 | -6.42% |
| Dec 31, 2023 | 358 | -171 | -32.33% |
| Dec 31, 2022 | 529 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Chemclin Diagnostics | 580 |
| Berry Genomics Co.,Ltd | 1,331 |
| Medicalsystem Biotechnology | 1,936 |
| SMO ClinPlus CO.,LTD. | 4,526 |
| Guangdong Hybribio Biotech | 1,990 |
| Shanghai Labway Clinical Laboratory | 1,245 |
| Thalys Medical Technology Group | 1,045 |
| Cowealth Medical China | 161 |